Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Cheng Lee

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|September 28, 2021
Aryl Hydrocarbon Receptor Defect Attenuates Mitogen-Activated Signaling through Leucine-Rich Repeats and Immunoglobulin-like Domains 1 (LRIG1)-Dependent EGFR DegradationHan-Lin Hsu, Hong-Kai Chen, Chi-Hao Tsai, et al.
Biomedicines|October 23, 2021
A New Light on Potential Therapeutic Targets for Colorectal Cancer TreatmentWei-Lun Tsai, Chih-Yang Wang, Yu-Cheng Lee, et al.
Endocrine Pathology|April 20, 2024
Clinicopathologic Features and Cytologic Correlation of ALK-Rearranged Papillary Thyroid Carcinoma: A Series of Eight CasesKun-Ping Shih, Yu-Cheng Lee, Jia-Jiun Tsai, et al.
Redox Biology|August 29, 2025
Metastatic breast cancer cells are vulnerable to fatty acid oxidation inhibition through DDX3-DRP1-mediated mitochondrial plasticityWen-Jing Hsu, Ming-Chien Hsu, Cheng-Ying Chu, et al.
Scientific Reports|November 25, 2025
Tumor-derived lactate fuels the STAT3-LCN2 pathway to promote bladder cancer malignancy and chemoresistanceShih-Yu Yu, Hao-Yi Li, Chi-Yun Wang, et al.
Journal of Colloid and Interface Science|January 24, 2025
Hypoxia-Targeted-Therapy: Mussel-inspired hollow polydopamine nanocarrier containing MoS<sub>2</sub> nanozyme and tirapazamine with anti-angiogenesis property for synergistic tumor therapyGirum Getachew Demissie, Yi-Chia Chen, Sin-Yi Ciou, et al.
Breast Cancer Research and Treatment|February 23, 2013
TCH-1030 targeting on topoisomerase I induces S-phase arrest, DNA fragmentation, and cell death of breast cancer cellsYu-Peng Liu, Hui-Ling Chen, Cherng-Chyi Tzeng, et al.
Chang Gung Medical Journal|September 12, 2008
Relationship between unstimulated salivary flow rate and saliva composition of healthy children in TaiwanKatie P Wu, Jyh-Yuh Ke, Chia-Ying Chung, et al.
Journal of the National Cancer Institute|August 3, 2022
Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint TherapySungyong You, Minhyung Kim, Xen Ping Hoi, et al.
Fluids and Barriers of the CNS|April 24, 2023
Blue light exposure collapses the inner blood-retinal barrier by accelerating endothelial CLDN5 degradation through the disturbance of GNAZ and the activation of ADAM17Yen-Ju Chan, George Hsiao, Wang-Nok Wan, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|September 28, 2021
Aryl Hydrocarbon Receptor Defect Attenuates Mitogen-Activated Signaling through Leucine-Rich Repeats and Immunoglobulin-like Domains 1 (LRIG1)-Dependent EGFR DegradationHan-Lin Hsu, Hong-Kai Chen, Chi-Hao Tsai, et al.
Biomedicines|October 23, 2021
A New Light on Potential Therapeutic Targets for Colorectal Cancer TreatmentWei-Lun Tsai, Chih-Yang Wang, Yu-Cheng Lee, et al.
Endocrine Pathology|April 20, 2024
Clinicopathologic Features and Cytologic Correlation of ALK-Rearranged Papillary Thyroid Carcinoma: A Series of Eight CasesKun-Ping Shih, Yu-Cheng Lee, Jia-Jiun Tsai, et al.
Redox Biology|August 29, 2025
Metastatic breast cancer cells are vulnerable to fatty acid oxidation inhibition through DDX3-DRP1-mediated mitochondrial plasticityWen-Jing Hsu, Ming-Chien Hsu, Cheng-Ying Chu, et al.
Scientific Reports|November 25, 2025
Tumor-derived lactate fuels the STAT3-LCN2 pathway to promote bladder cancer malignancy and chemoresistanceShih-Yu Yu, Hao-Yi Li, Chi-Yun Wang, et al.
Journal of Colloid and Interface Science|January 24, 2025
Hypoxia-Targeted-Therapy: Mussel-inspired hollow polydopamine nanocarrier containing MoS<sub>2</sub> nanozyme and tirapazamine with anti-angiogenesis property for synergistic tumor therapyGirum Getachew Demissie, Yi-Chia Chen, Sin-Yi Ciou, et al.
Breast Cancer Research and Treatment|February 23, 2013
TCH-1030 targeting on topoisomerase I induces S-phase arrest, DNA fragmentation, and cell death of breast cancer cellsYu-Peng Liu, Hui-Ling Chen, Cherng-Chyi Tzeng, et al.
Chang Gung Medical Journal|September 12, 2008
Relationship between unstimulated salivary flow rate and saliva composition of healthy children in TaiwanKatie P Wu, Jyh-Yuh Ke, Chia-Ying Chung, et al.
Journal of the National Cancer Institute|August 3, 2022
Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint TherapySungyong You, Minhyung Kim, Xen Ping Hoi, et al.
Fluids and Barriers of the CNS|April 24, 2023
Blue light exposure collapses the inner blood-retinal barrier by accelerating endothelial CLDN5 degradation through the disturbance of GNAZ and the activation of ADAM17Yen-Ju Chan, George Hsiao, Wang-Nok Wan, et al.
Pageof 6